Researchers
Principal Investigators
|
|
Professor Sarah Lewington co-leads the “Large-scale observational studies in diverse populations” within the MRC’s Population Health Research Unit (PHRU). She is the Oxford-based principal investigator for large cohort studies conducted in Russia (200K participants), Cuba (150K participants) and India (500K participants). She has published >100 articles which have >22,000 citations (Scopus h-index, 43).
|
Co-Investigators University of Oxford
|
Associate Professor Naomi Allen |
Associate Professor Naomi Allen is Senior Epidemiologist for UK Biobank, which is currently performing an imaging sub-study of DXA and MRI imaging in 100,000 participants. She also has research interests in the role of adiposity in cancer development. She has published >300 articles that have been cited >19,000 times (Scopus h-index, 78)
|
|
Associate Professor Jonathan Emberson
|
Associate Professor Jonathan Emberson is a senior statistician and epidemiologist and is the UK Principal Investigator of the Mexico City Prospective Study (150K participants). Based at the MRC PHRU in Oxford, his research is focused on studying the causes and prevention of cardiovascular
(and related) diseases. He has published >100 articles which have been cited ~20,000 times (Scopus h-index, 43). |
|
Dr Ben Lacey
|
Dr Ben Lacey is an epidemiologist and consultant public health physician. He is Senior Clinical Research Fellow at the Nuffield Department of Population Health, University of Oxford. He works on large-scale cohort studies in several low and middle income countries, focusing particularly on the effect of adiposity on vascular disease risk. He has published 30 articles (Scopus h-index, 7). |
|
Professor Fredrik Karpe
|
Professor Fredrik Karpe is head of OCDEM and founded the Oxford Biobank which has a large DXA-based cohort (n=5,500). His research has been in human metabolism in relation to obesity, type 2 diabetes and cardiovascular disease. He has published >200 articles which have >26,000 citations (Scopus h-index, 73). |
Co-Investigators (Malaysia)
Associate Professor Dr. Nor Azian Murad
|
Associate Professor Dr. Nor Azian Murad is a Research Fellow at UKM Medical Molecular Biology Institute (UMBI). Her research interest is in non-communicable diseases focusing on genetic predisposition as well as gene-environment interaction. She has published 25 articles (Scopus h-index, 5). |
Professor Rahman Jamal
|
Professor Datuk Dr A Rahman A Jamal is the principal investigator for The Malaysian Cohort study. His research has involved Genetic Markers of Cancer, Cancer Proteomics, Paediatric Hematological Disorders (Thalassemia and Leukemia), Stem Cell Therapy, Microgravity Science, Cancer and Microbiome. He has published 131 research articles (Scopus h-index, 20) of which 20 have been from The Malaysia Cohort. |
Associate Professor Dr. Norlaila Mustafa
|
Associate Professor Dr. Norlaila Mustafa is a consultant endocrinologist. Her research focuses on
endocrinology diseases, diabetes mellitus and obesity. She has published 36 articles (Scopus h index, 9). |
Dr Chin Siok Fong
|
Dr Chin Siok Fong main research areas are in proteomics and metabolomics and she is
responsible for performing and analyzing the DXA scan images for participants in The Malaysian Cohort study. She has published 11 articles (Scopus h-index, 4).
|
Dr Noraidatulakma Abdullah
|
Dr Noraidatulakma Abdullah is a medical statistician and epidemiologist. Currently she is working with The Malaysian Cohort data. She has published 16 articles (Scopus h-index, 3). |